Additional Information
Market: OTCBB
Sector: Healthcare, Equipment & Services
EPIC: POSC
Latest Price: $0.01  (0,00%)
52-week High: $0.00
52-week Low: $0.00
Market Cap: $2.40M
1 year chart
1 day chart
Watchlist/Portfolio

Add to watchlist:

Only registered members can add into watchlist !

Register here !
Positron Corporation
www.positron.com

Positron Corporation offers innovative solutions through the production and distribution of molecular
imaging systems and radiopharmaceutical technologies.

Pdf

Positron's automated radiopharmaceutical system readies for commercial deployment

1st Apr 2011, 8:16 pm by Deborah Sterescu

Positron Corp (OTCBB: POSC) said Monday that its automated radiopharmaceutical system, PosiRx, has met the test standards required to be commercially distributed.

The Indianapolis-based molecular imaging company, which specializes in the field of nuclear cardiology, has developed a system that automates and simplifies the dose preparation and dispensing processes for radiopharmaceutical agents used in molecular imaging.

Radiopharmaceuticals, which feature radioactive isotopes, are used in the field of nuclear medicine as tracers in the diagnosis and treatment of many diseases.

Following internal testing of its new system, Positron retained the services of the University of New Mexico to assist in developing tests and validation protocols. 
 
Last month, the company said it installed a PosiRx Beta system at the university, and recently, the system successfully completed testing of key criteria, including air quality, ensuring proper radiochemical purity of kits, product sterility, and dose accuracy, among others.

No investment advice

The Company is a publisher and is not registered with or authorised by the Financial Services Authority (FSA). You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is suitable or advisable for any specific person. You further understand that none of the information providers or their affiliates will advise you personally concerning the nature, potential, advisability, value or suitability of any particular security, portfolio of securities, transaction, investment strategy, or other matter.

You understand that the Site may contain opinions from time to time with regard to securities mentioned in other products, including company related products, and that those opinions may be different from those obtained by using another product related to the Company. You understand and agree that contributors may write about securities in which they or their firms have a position, and that they may trade such securities for their own account. In cases where the position is held at the time of publication and such position is known to the Company, appropriate disclosure is made. However, you understand and agree that at the time of any transaction that you make, one or more contributors may have a position in the securities written about. You understand that price and other data is supplied by sources believed to be reliable, that the calculations herein are made using such data, and that neither such data nor such calculations are guaranteed by these sources, the Company, the information providers or any other person or entity, and may not be complete or accurate.

From time to time, reference may be made in our marketing materials to prior articles and opinions we have published. These references may be selective, may reference only a portion of an article or recommendation, and are likely not to be current. As markets change continuously, previously published information and data may not be current and should not be relied upon.